Zydus Receives Final Approval From The USFDA For Plerixafor Injection

Zydus Receives Final Approval From The USFDA For Plerixafor Injection

Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant.

FPJ Web DeskUpdated: Thursday, July 27, 2023, 01:32 PM IST
article-image
Zydus Receives Final Approval From The USFDA For Plerixafor Injection | Image: Zydus (Representative)

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial, the company on Thursday announced through an exchange filing.

Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant. The drug will be manufactured at the group’s injectable manufacturing facility of Zydus Lifesciences Ltd. (Alidac) at SEZ, Ahmedabad (India).

Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial had annual sales of USD 210 million in the United States.

The group now has 374 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences Ltd Shares

The shares of Zydus Lifesciences Ltd on Thursday at 1:28 pm IST were at ₹654.40, up by 5.08 percent.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Air India Enters Into Codeshare Pact With AIX Connect

Air India Enters Into Codeshare Pact With AIX Connect

Media aficionado, Dinesh Anand To Launch Channel DAP TV Network Under Banner Dinesh Anand Production...

Media aficionado, Dinesh Anand To Launch Channel DAP TV Network Under Banner Dinesh Anand Production...

Sapphire Foods India Announces Equity Shares To Employees As Stock Option

Sapphire Foods India Announces Equity Shares To Employees As Stock Option

Strides Pharma To Demerge CDMO, Soft Gelatin Biz Into Separate Entity

Strides Pharma To Demerge CDMO, Soft Gelatin Biz Into Separate Entity

Birla Estates Announces Launch Of Birla Trimaya Phase 1 In Bengaluru With A Revenue Potential Of...

Birla Estates Announces Launch Of Birla Trimaya Phase 1 In Bengaluru With A Revenue Potential Of...